Evidence map›Paper›PMID 23902760›Full record

ArticleThe Journal of biological chemistry2013

Phosphorylation regulates myo-inositol-3-phosphate synthase: a novel regulatory mechanism of inositol biosynthesis.

Rania M Deranieh, Quan He, Joseph A Caruso, Miriam L Greenberg

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
8.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Disorder-to-order active site capping regulates the rate-limiting step of the inositol pathway.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. DecipheringmSystems · 2024
    Article
  6. Article
  7. Article
  8. Inositol depletion regulates phospholipid metabolism and activates stress signaling in HEK293T cells.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Roles of vitamins in stem cells.Cellular and molecular life sciences : CMLS · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rania M DeraniehFrom the Department of Biological Sciences and.
Quan He
Joseph A Caruso
Miriam L Greenberg
Wayne State University · US

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI PAUL M STEMMER · 1985 to 2026
$68.4M
RESEARCH CORE-- SIGNAL TRANSDUCTIONP30ES006639 · NIEHS · WAYNE STATE UNIVERSITY · PI DERESKI, MARY O · 1994 to 2008
$13.1M
A NOVEL MECHANISM OF REGULATION OF INOSITOL BIOSYNTHESIS IN YEASTR01DK081367 · NIDDK · WAYNE STATE UNIVERSITY · PI GREENBERG, MIRIAM L · 2009 to 2012
$1.5M
NCI NIH HHS P30 CA022453NCI NIH HHS P30 CA22453NIDDK NIH HHS DK 081367NIDDK NIH HHS R01 DK081367NIEHS NIH HHS P30 ES006639NIEHS NIH HHS P30 ES06639
6 · The paper itself

Abstract

myo-Inositol-3-phosphate synthase (MIPS) plays a crucial role in inositol homeostasis. Transcription of the coding gene INO1 is highly regulated. However, regulation of the enzyme is not well defined. We previously showed that MIPS is indirectly inhibited by valproate, suggesting that the enzyme is post-translationally regulated. Using (32)Pi labeling and phosphoamino acid analysis, we show that yeast MIPS is a phosphoprotein. Mass spectrometry analysis identified five phosphosites, three of which are conserved in the human MIPS. Analysis of phosphorylation-deficient and phosphomimetic site mutants indicated that the three conserved sites in yeast (Ser-184, Ser-296, and Ser-374) and humans (Ser-177, Ser-279, and Ser-357) affect MIPS activity. Both S296A and S296D yeast mutants and S177A and S177D human mutants exhibited decreased enzymatic activity, suggesting that a serine residue is critical at that location. The phosphomimetic mutations S184D (human S279D) and S374D (human S357D) but not the phosphodeficient mutations decreased activity, suggesting that phosphorylation of these two sites is inhibitory. The double mutation S184A/S374A caused an increase in MIPS activity, conferred a growth advantage, and partially rescued sensitivity to valproate. Our findings identify a novel mechanism of regulation of inositol synthesis by phosphorylation of MIPS.

Indexed as

Gene Expression Regulation, EnzymologicAmino Acid SequenceBinding SitesCatalysisEscherichia coliHumansInositolIntramolecular LyasesMolecular Sequence DataMutagenesis, Site-DirectedMutationPhospholipidsPhosphoproteinsPhosphorylationProtein BindingProtein ConformationD-myo-inositol-3-phosphate synthaseInositolIntramolecular LyasesPhospholipidsPhosphoproteinsSaccharomyces cerevisiae ProteinsSerineValproic AcidInositol 1myo-Inositol Phosphate SynthasePhospholipid MetabolismPhosphorylationPhosphorylation Site MutantsPost-translational ModificationValproateYeast

Identifiers

PMID23902760
PMCPMC3772229
OpenAlexW1965437539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.